Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.
about
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseHow we treat chronic graft-versus-host disease.A "window of opportunity" for patients with late-onset pulmonary dysfunction after allogeneic hematopoietic cell transplantationNational Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aBlood and marrow transplant clinical trials network state of the Science Symposium 2014National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediaMeasuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reporFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Inhibition of tumor necrosis factor alpha reduces the outgrowth of hepatic micrometastasis of colorectal tumors in a mouse model of liver ischemia-reperfusion injury.New Insights Into Multicenter PICU Mortality Among Pediatric Hematopoietic Stem Cell Transplant Patients.How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
P2860
Q26827651-F796DC24-521C-40DF-BD85-EDE30BAAEB9FQ28076264-BBF531CF-1C57-4A6A-B3F1-6F3C7B5EC3EDQ35004923-2269FDC0-2E17-40B3-BADD-F3291933F038Q35445239-1533EA0D-CA48-40E9-BB84-F1F73F24D724Q35549037-F22C6D39-581D-44EC-8309-56FC1B35D571Q35591760-411ABF87-2990-43DE-AD04-3A4ED00BA632Q35762578-E4475E94-AB00-4254-88CE-FEE4548EF5ADQ36554724-A1ACD2EE-0AD5-46B6-9941-4A77FEDB445AQ36712018-B159C673-73E5-4B26-92A2-E452EB1EEA58Q37276584-4ACF57DB-6310-465B-B8BA-487919CB3E4EQ37516970-87DD4F45-15A7-4F43-A39F-D82143AFE59FQ37597740-7FCBF53A-100A-4E60-AB88-70529AE31099Q37609903-09DA2035-6C1C-4174-BA5D-3161286CFADD
P2860
Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@ast
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@en
type
label
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@ast
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@en
prefLabel
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@ast
Soluble tumor necrosis factor ...... eic stem cell transplantation.
@en
P2093
P2860
P50
P1476
Soluble tumor necrosis factor ...... neic stem cell transplantation
@en
P2093
Carrie L Kitko
Gregory A Yanik
Kenneth R Cooke
Mark T Vander Lugt
Shin Mineishi
Thomas Braun
P2860
P304
P356
10.1016/J.BBMT.2011.11.031
P577
2011-12-10T00:00:00Z